Alerts will be sent to your verified email
Verify EmailSOLARA
Solara Active Pharma
|
Jubilant Pharmova
|
Aarti Pharmalabs
|
|
---|---|---|---|
Operational Metrics
|
|||
API Sector
|
|||
Manufacturing Capacity - Ibuprofen
|
5000.0 MTPA | n/a | n/a |
US DMF Filings
|
230.0 . | 98.0 . | n/a |
Financials
|
|||
5 yr Average ROE
|
5.09 % | 10.45 % | 6.41 % |
5yr average Equity Multiplier
|
1.89 | 2.05 | 1.33 |
5yr Average Asset Turnover Ratio
|
0.58 | 0.64 | 0.49 |
5yr Avg Net Profit Margin
|
4.11 % | 8.17 % | 6.71 % |
Price to Book
|
1.33 | 2.0 | 2.79 |
P/E
|
0.0 | 285.2 | 23.78 |
5yr Avg Cash Conversion Cycle
|
138.45 Days | -3.54 Days | 76.86 Days |
Inventory Days
|
90.89 Days | 78.49 Days | 81.9 Days |
Days Receivable
|
129.77 Days | 54.89 Days | 76.62 Days |
Days Payable
|
142.99 Days | 167.25 Days | 54.09 Days |
5yr Average Interest Coverage Ratio
|
1.64 | 4.68 | 9.13 |
5yr Avg ROCE
|
8.8 % | 10.85 % | 8.88 % |
5yr Avg Operating Profit Margin
|
16.58 % | 20.24 % | 11.72 % |
5 yr average Debt to Equity
|
0.59 | 0.71 | 0.15 |
5yr CAGR Net Profit
|
n/a | n/a | n/a |
5yr Average Return on Assets
|
2.82 % | 5.11 % | 4.27 % |
Shareholdings
|
|||
Promoter Holding
|
30.49 % | 50.68 % | 46.46 % |
Share Pledged by Promoters
|
47.99 % | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-13.62 % | 0.0 | 0.48 % |
Change in Mutual Fund Holding (3 Yrs)
|
-1.9 % | 1.49 % | -2.39 % |
Solara Active Pharma
|
Jubilant Pharmova
|
Aarti Pharmalabs
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
-
|